Skip to main content Deutsch

Funded Projects

Funded Projects

2022-2026  "Pre-clinicAl Ion beam Research – PAIR", Doc.funds.connect awarded by FWF, Project Lead at MedUni Wien D. Georg; additional faculty from MedUni Vienna: B. Knäusl, J. Loizou (Department of Medicine I, Institute of Cancer Research) and T. Helbich (Department of Biomedical Imaging and Image-guided Therapy)
2021-2025 "Real-Time adaptive proton therapy of cancer – RAPTOR", Innovative Training Network (ITN) project awarded by EC, Project Lead at MedUni Wien D. Georg and B. Knäusl
2019- „Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized open labeled phase III trial“ Project funded by SAKK/ABCSG; Project leader: D. Kauer-Dorner (Principal Investigator: C. Singer, MedUni Vienna, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology; R. Exner, MedUni Vienna, Department of Surgery)
2019-2023 A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant  Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous CellCarcinoma (LA HNSCC) – Kurztitel  MK-3475-689 LAHNSCC“ G. Altorjai  (Principal Investigator Univ.-Kl. für Inn. Med. I, Th. Füreder)
2019-2023 „Image guided intensity modulated External beam radiochemotherapy and MRI based adaptive Brachytherapy in locally advanced CErvical cancer“ - EMBRACE studies“; Project funded by Nucletron; Project leader: C. Kirisits
2019-2022  "Proton and carbon ion response studies for chondrosarcoma – going beyond current radiobiological standards with 3D models", Project Leader Physics D. Georg (Project leader Biology and principal investigator B. Lohberger)
2019-2022 Image guided particle therapy of uveal melanoma with a multiport beam arrangement – IMPACTOR“ D. Georg
2019-2020 „A multi-centre, open-label, single-arm, dose-finding phase I/II study to evaluate safety, tolerability, dosing schedule, and preliminary efficacy of  carrier-added 4-L-[131I]iodo-phenylalanine (131I-IPA), administered as single or repetitive injections in patients with recurrent glioblastoma multiforme (GBM), concomitantly to 2nd line external radiation therapy  (XRT) - IPAX-1Study“ K. Dieckmann (Principal Investigator Univ.-Kl. für Radioonkologie und Nuklearmedizin, Klinische Abtlg. für Nuklearmedizin T. Traub-Weidinger)
2015-2021 „Individualized Adaptive Radiotherapy in Cervix Cancer - EMBRACE II“ Project funded by Nucletron
2013-2020 "AGMT_HNO-2: Randomisierte Phase II Pilot Studie: Induktionstherapie mit  Docetaxel, Cisplatin und Cetuximab versus  Docetaxel, Cisplatin und 5 FU gefolgt Kopf-Hals Tumoren – Proj.Nr.: HNO-2", G. Altorjai